Drugs / CJ-50300
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00336635 | Jun 2006 → Feb 2007 | smallpox | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00607243 | Jan → Jun 2008 | smallpox | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT01317238 | Oct 2010 → Jul 2011 | smallpox | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT01056770 | Oct 2009 → Dec 2010 | smallpox | Seoul National University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CJ-50300 | “The aim of the present study was to investigate the kinetics of humoral and cell-mediated immune responses to a new cell culture-derived smallpox vaccine (CJ-50300, CJ...” PMID 17597266 ↗ Jun 2007 |
| Modality | Vaccine | “cell-culture derived smallpox vaccine (CJ-50300)” NCT01056770 ↗ |